Unique ID issued by UMIN | UMIN000012553 |
---|---|
Receipt number | R000014689 |
Scientific Title | A double-blind, placebo controlled, randomized trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the incidence of wound complications in patients with open surgery. |
Date of disclosure of the study information | 2013/12/12 |
Last modified on | 2024/06/19 14:25:01 |
A double-blind, placebo controlled, randomized trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the incidence of wound complications in patients with open surgery.
A double-blind, placebo controlled, randomized trial of Abound in patients with open surgery.
A double-blind, placebo controlled, randomized trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the incidence of wound complications in patients with open surgery.
A double-blind, placebo controlled, randomized trial of Abound in patients with open surgery.
Japan |
Gastrointestinal malignant tumor
Gastrointestinal surgery |
Malignancy
NO
To evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the incidence of wound complications in patients with open surgery.
Efficacy
Exploratory
Pragmatic
Phase II
The incidence of wound complications
The incidence of postoperative complications except wound complications, Postoperative hospital stay, muscle mass (skeletal muscle mass, grip strength), moisture content of the skin.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Food |
A: Abound
B: placebo (orange juice)
20 | years-old | <= |
Not applicable |
Male and Female
1) Planning open surgery for gastrointestinal stromal tumors.
2) Aged 20 or older.
3) Adequate organ function.
4) Judgement as being able to take orally preoperatively.
5) An ECOG performance status of 0 or 1.
6) Written informed consent.
1) Previous abdominal operative scar.
2) Emergency surgery.
3) Uncontrollable diabetes millutus or administration of insulin.
4) Systemic steroids medication.
5) Active bacterial or fungous infection.
6) Other conditions judged as inappropriate for the study by the investigator.
60
1st name | Yuichiro |
Middle name | |
Last name | Doki |
Osaka University Graduate School of Medicine
Department of astroenterological Surgery
5650871
2-2 E2, Yamadaoka, Suita, Osaka 565-0781, JAPAN
06-6879-3251
ydoki@gesurg.med.osaka-u.ac.jp
1st name | Yukinori |
Middle name | |
Last name | Kurokawa |
Osaka University Graduate School of Medicine
Department of astroenterological Surgery
5650871
2-2 E2, Yamadaoka, Suita, Osaka 565-0781, JAPAN
06-6879-3251
ykurokawa@gesurg.med.osaka-u.ac.jp
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
Self funding
Japan
Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine
2-2 E2, Yamadaoka, Suita, Osaka
0668793251
nwada@gesurg.med.osaka-u.ac.jp
NO
大阪大学医学部付属病院
2013 | Year | 12 | Month | 12 | Day |
Unpublished
No longer recruiting
2013 | Year | 11 | Month | 13 | Day |
2013 | Year | 12 | Month | 13 | Day |
2014 | Year | 12 | Month | 31 | Day |
2015 | Year | 09 | Month | 15 | Day |
2015 | Year | 09 | Month | 30 | Day |
2015 | Year | 12 | Month | 31 | Day |
2013 | Year | 12 | Month | 11 | Day |
2024 | Year | 06 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014689